Providers Push Back on 340B Rebate Model

Providers push back on 340B rebate model

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.

HRSA Receives More than 5,500 Comments on 340B Rebate RFI

The Health Resources and Services Administration (HRSA) received more than 5,500 comments on its request for information (RFI) on a [...] The post HRSA Receives More than 5,500 Comments on 340B Rebate RFI appeared first on 340B Report.

AHA urges HRSA to abandon 340B rebate model that will cost billions and jeopardize access to care for millions

The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program because “a rebate mechanism of any kind is flawed in both conception and design,” the AHA told  the agency today. Responding to a request for information, the AHA shared many concerns about how a rebate model would deviate from the purpose of the 340B program. “[I]t will inflict more than a billion dollars in costs annually on t…